Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Becky Hallinan"'
Autor:
Barbara Bowers, Martin N. Raber, Paul Y. Holoye, Becky Hallinan, James Young, Rodger J. Winn, Joseph Readling, Karen Hoelzer, Frank V. Fossella, Waun Ki Hong
Publikováno v:
Investigational New Drugs. 10:331-335
We treated 34 chemotherapy-naive patients with stage IIIb or IV non-small cell lung cancer with trimetrexate 150-200 mg/m2 intravenously over 30 minutes every two weeks. Six of 31 evaluable patients (19%) achieved a partial response. The major toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9173a368950572b741d56ae77273abed
https://doi.org/10.1007/bf00944191
https://doi.org/10.1007/bf00944191
Autor:
Becky Hallinan-Fueger, Janis Newman, Rodger J. Winn, Jaffer A. Ajani, Thomas Maher, Luis Baez, Theodore Pollock
Publikováno v:
Cancer investigation. 12(5)
Merbarone, 5-(N-phenylcarboxamido)-2-thiobarbituric acid (NSC 336628), is a derivative of barbituric acid and represents a unique class of antineoplastic agents. We treated 16 patients with advanced gastric carcinoma in a phase II study of merbarone.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83c82de51578cc8b6b8a22ac7c920afa
https://pubmed.ncbi.nlm.nih.gov/7922705
https://pubmed.ncbi.nlm.nih.gov/7922705
Autor:
Larry Holden, Rodger J. Winn, Karen Harper, Paul Y. Holoye, Heather Allen, Martin N. Raber, Robert Belt, Becky Hallinan, Frank V. Fossella
Publikováno v:
Investigational new drugs. 9(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4c05f94cd63668c92fa6428bb46a75
https://pubmed.ncbi.nlm.nih.gov/1666631
https://pubmed.ncbi.nlm.nih.gov/1666631